A fair innings for NICE?

Pharmacoeconomics. 2002;20(6):389-91. doi: 10.2165/00019053-200220060-00003.
No abstract available

Publication types

  • Comment

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / economics*
  • Confidence Intervals
  • Cost-Benefit Analysis
  • Data Interpretation, Statistical*
  • Excitatory Amino Acid Antagonists / economics
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Humans
  • Quality-Adjusted Life Years*
  • Riluzole / economics
  • Riluzole / therapeutic use
  • Statistics, Nonparametric
  • United Kingdom

Substances

  • Excitatory Amino Acid Antagonists
  • Riluzole